Quarterly Returns (%)Teva Pharmaceutical Industries Limited
Years | Q1 | Q2 | Q3 | Q4 | Annual |
---|---|---|---|---|---|
1990 | 0 | 4 | -18.5 | 18.2 | 0 |
1991 | 19.2 | -6.5 | 48.3 | 0 | 65.4 |
1992 | 32.6 | -7 | 28.3 | 48.5 | 134.9 |
1993 | 3 | -8.7 | 43.2 | 2.2 | 37.6 |
1994 | -17.3 | -3.5 | 18 | -14.5 | -19.4 |
1995 | 25 | 24.3 | -3.5 | 25.6 | 92.9 |
1996 | -16.7 | 0 | 19.9 | 8.3 | 8.8 |
1997 | 10.6 | 16.9 | -13.8 | -14.9 | -5.1 |
1998 | -9.4 | -17.3 | 7.2 | 7.8 | -13.5 |
1999 | 16.6 | 3.6 | 3 | 42.5 | 77.2 |
2000 | 4.1 | 48.9 | 32.1 | 2.2 | 105 |
2001 | -25.4 | 20.6 | -2.5 | 0.9 | -15.6 |
2002 | -11.2 | 26.1 | 2.2 | 15.5 | 26 |
2003 | 8 | 36.9 | 0.7 | -0.7 | 47.9 |
2004 | 11.9 | 6.2 | 53.8 | 15.3 | 110.6 |
2005 | 4.1 | 0.7 | 7.5 | 28.9 | 45.2 |
2006 | -4.1 | -23.2 | 8.2 | -7.4 | -27.1 |
2007 | 20.7 | 10.6 | 6.8 | 3.7 | 51 |
2008 | -0.4 | -0.5 | 0.2 | -6.8 | -7.4 |
2009 | 6.2 | 9.9 | 2.8 | 11.5 | 33.6 |
2010 | 12.7 | -17.3 | 1.9 | -0.8 | -5.9 |
2011 | -3.4 | -3.4 | -22.4 | 9 | -21.1 |
2012 | 12.3 | -12.9 | 6.2 | -8.6 | -5.1 |
2013 | 7.1 | -0.1 | -2.4 | 7 | 10.9 |
2014 | 32.8 | -0.1 | 3.2 | 7.6 | 47.3 |
2015 | 9 | -4.6 | -4 | 16.9 | 16.7 |
2016 | -18 | -5.5 | -7.8 | -20.5 | -43.2 |
2017 | -10.6 | 4.8 | -46.7 | 3.2 | -46 |
2018 | -9.8 | 45 | -12 | -28.2 | -18.6 |
2019 | 1.7 | -41.4 | -27.1 | 47.3 | -35.3 |
2020 | -5 | 4 | 8 | 7.1 | -3.3 |
2021 | 19.6 | -14.2 | -1.6 | -17.8 | -17 |
2022 | 17.2 | -19.9 | 7.3 | 13.1 | 13.9 |
2023 | -3.1 | -14.9 | 35.6 | 4.5 | 14.5 |
2024 | 35 | 17 | 7.5 | 26.9 | 111 |
2025 | -3.6 | 0 | 0 | -3.6 |